These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 14587168)

  • 61. [Therapeutic strategies to improve the outcome of patients with diabetes mellitus and acute coronary syndrome].
    Cavallini C
    G Ital Cardiol (Rome); 2006 Apr; 7(4 Suppl 1):13S-20S. PubMed ID: 16749287
    [TBL] [Abstract][Full Text] [Related]  

  • 62. An analysis of the Association of Society of Chest Pain Centers Accreditation to American College of Cardiology/American Heart Association non-ST-segment elevation myocardial infarction guideline adherence.
    Chandra A; Glickman SW; Ou FS; Peacock WF; McCord JK; Cairns CB; Peterson ED; Ohman EM; Gibler WB; Roe MT
    Ann Emerg Med; 2009 Jul; 54(1):17-25. PubMed ID: 19282062
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Glycoprotein IIb/IIIa inhibition and long-term benefit: the stuff of dreams?
    Montalescot G
    Eur Heart J; 2004 Sep; 25(18):1562-4. PubMed ID: 15351154
    [No Abstract]   [Full Text] [Related]  

  • 64. [Fibrinolytic intervention in acute myocardial infarction].
    Nielsen JD
    Ugeskr Laeger; 1984 Jan; 146(4):259-65. PubMed ID: 6367178
    [No Abstract]   [Full Text] [Related]  

  • 65. Fibrinolytic drugs in acute myocardial infarction.
    Drug Ther Bull; 1988 Jun; 26(12):45-8. PubMed ID: 3292184
    [No Abstract]   [Full Text] [Related]  

  • 66. Reperfusion therapy for acute myocardial infarction: drugs or devices? Is this the right question?
    Pavlides GS; Cokkinos DV
    Clin Cardiol; 2004 May; 27(5):254-6. PubMed ID: 15188937
    [No Abstract]   [Full Text] [Related]  

  • 67. [Thrombolytic treatment in acute myocardial infarction].
    Røde R
    Tidsskr Nor Laegeforen; 1989 Feb; 109(4):428-9. PubMed ID: 2645687
    [No Abstract]   [Full Text] [Related]  

  • 68. Reperfusion therapy for acute myocardial infarction.
    McPherson JA; Gibson RS
    Emerg Med Clin North Am; 2001 May; 19(2):433-49, xii. PubMed ID: 11373988
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Myocardial infarction and heparin revisited.
    Conti CR
    Clin Cardiol; 1995 Nov; 18(11):607. PubMed ID: 8590527
    [No Abstract]   [Full Text] [Related]  

  • 70. Pharmacologic reperfusion therapy for acute myocardial infarction.
    Lowe HC; Neill BD; Van de Werf F; Jang IK
    J Thromb Thrombolysis; 2002 Dec; 14(3):179-96. PubMed ID: 12913398
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Door-to-balloon time and ST-segment elevation myocardial infarction.
    Conti CR
    JACC Cardiovasc Interv; 2011 Sep; 4(9):1051; author reply 1051-1052. PubMed ID: 21939950
    [No Abstract]   [Full Text] [Related]  

  • 72. The general concepts of an equivalence trial, applied to ASSENT-2, a large-scale mortality study comparing two fibrinolytic agents in acute myocardial infarction.
    Lesaffre E; Bluhmki E; Wang-Clow F; Berioli S; Danays T; Fox NL; Van de Werf F
    Eur Heart J; 2001 Jun; 22(11):898-902. PubMed ID: 11428813
    [No Abstract]   [Full Text] [Related]  

  • 73. Questions linger in choice of thrombolytics.
    Berek B
    Hosp Technol Ser; 1994 Jul; 13(9):1-3. PubMed ID: 10134921
    [No Abstract]   [Full Text] [Related]  

  • 74. Pharmacotherapy during percutaneous coronary intervention in acute myocardial infarction.
    Rognoni A
    Cardiovasc Hematol Agents Med Chem; 2013 Jun; 11(2):83. PubMed ID: 22963496
    [No Abstract]   [Full Text] [Related]  

  • 75. [Ischemic heart disease (VII). Determinants of functional recovery after thrombolytic treatment].
    Suárez de Lezo J; Pan M; Romero M; Segura J; Sancho M
    Rev Esp Cardiol; 1988; 41(7):426-36. PubMed ID: 3247503
    [No Abstract]   [Full Text] [Related]  

  • 76. Protection of the myocardium during myocardial infarction: pharmacologic protection during thrombolytic therapy.
    Willerson JT; Buja LM
    Am J Cardiol; 1990 May; 65(19):35I-41I. PubMed ID: 2186610
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Treatment of acute myocardial infarction with defibrotide.
    Mattioli G; Cappello C; Fusaro MT
    Semin Thromb Hemost; 1989 Oct; 15(4):470-3. PubMed ID: 2814517
    [No Abstract]   [Full Text] [Related]  

  • 78. Myocardial infarction: review of clinical trials and treatment strategies.
    Casey K; Bedker DL; Roussel-McElmeel PL
    Crit Care Nurse; 1998 Apr; 18(2):39-52; quiz 53-4. PubMed ID: 9708119
    [No Abstract]   [Full Text] [Related]  

  • 79. Large-scale trials of thrombolytic therapy for acute myocardial infarction: GISSI-2, ISIS-3, and GUSTO-1.
    Ridker PM; O'Donnell C; Marder VJ; Hennekens CH
    Ann Intern Med; 1993 Sep; 119(6):530-2. PubMed ID: 8357123
    [No Abstract]   [Full Text] [Related]  

  • 80. American Heart Association late-breaking clinical trials 2013.
    Eur Heart J; 2014 Jan; 35(3):134. PubMed ID: 24571037
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.